Second carcass-eating fly species cleared by FDA for maggot wound therapy
摘要
美国食品药品监督管理局（FDA）近日批准第二种以腐肉为食的蝇类用于蛆虫伤口疗法。新加坡公司Cuprina Holdings宣布，其新治疗幼虫被命名为MediFly Maggots。该公司成为唯一拥有FDA批准销售两种蝇类幼虫的企业，有望主导全球蛆虫市场。新获批物种为铜绿蝇（Lucilia cuprina），即澳大利亚羊绿蝇，与常用于伤口疗法的丝光绿蝇（Luc
The Food and Drug Administration this week cleared a second carcass-feasting fly species for use in maggot wound therapy, according to an announcement from Cuprina Holdings, a Singapore-based company that has dubbed its new therapeutic larvae MediFly Maggots.
With the clearance, Cuprina appears to be the only company to have FDA clearance to sell two species of fly larvae—and it's abuzz with the potential to dominate the global maggot market.
The new species is Lucilia cuprina, or Australian sheep blowfly. It's a close relative of Lucilia sericata, or the common green bottle fly, which is the fly species most often used for wound therapy, often called biosurgery or maggot debridement therapy (MDT). L. sericata is the only other fly with FDA clearance, which the agency first granted in 2004 to Ronald Sherman, who is now Cuprina’s Medical and Scientific Director.
转载信息
评论 (0)
暂无评论，来留下第一条评论吧